Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Colorectal cancer
MSI-H immunotherapy, BRAF V600E, HER2 and KRAS G12C combinations.
AACR Annual Meeting 2026
17–22 Apr 2026, San Diego · Cancer Research 86 (7_Supplement)
All 7,489 abstracts, including clinical trial (CT) and late-breaking (LB) abstracts, have Cancer Research supplement DOIs in Crossref.
Indexed in Crossref
176 abstracts matching colorectal cancer from the meeting's journal supplement, fetched live from Crossref 2026-11-12 10:40 UTC. This is a keyword search, not the complete abstract book.
- 2336Rectal and sigmoid colon cancers drive rising early-onset colorectal cancer incidence in the United StatesMichelle O. Nagata, Scott K. Kuwada, Linda Wong, Loïc Le Marchand et al.
- 2387Colorectal cancer equity and impact (CLEAR-CRC): The colorectal cancer alliance's community-based model for advancing biomarker testingKimberly Lynn Newcomer, Erin Siegel, David Fenstermacher, Marianne Pearson et al.
- 7915Molecular landscape of colorectal cancer (CRC) with KRAS 13D mutationsMasango Samuel, Yuliang Chen, Sarah Castillo, Chenbo Sun et al.
- 7775Pharmacodynamic biomarkers of TGFβR2xPD-1 bispecific antibody INCA33890 in patients with MSS metastatic colorectal cancer (mCRC)Michelle Kinder, Rui Hong, Chifei Sun, Yunlan Fang et al.
- 3954Identifying biomarkers of response in BRAF p.V600E mutant colorectal cancers (mCRC)Gagandeep Brar, Brooke Rhead, Unnati Jariwala, Stamatina Fragkogianni et al.
- 4863
- CT218Phase 1b/2 study of arfolitixorin in combination with 5-fluorouracil (5FU), oxaliplatin, and bevacizumab as first-line therapy for metastatic colorectal cancer (mCRC)Sebastian Stintzing, Arndt Stahler, Annabel Alig, Isabel Löwstedt et al.
- 6360Project Cure CRC: A patient-powered ecosystem uniting data, discovery and accelerating cures for colorectal cancerKim Newcomer, Travis Hyams, Tina Zeff, Marc Mason et al.
- 746Modeling micro- and nanoplastics-induced colon aging in organoids to unravel pathways leading to early-onset colorectal cancer.Zahra Heydari, Gobinda Sarkar, Lisa A. Boardman
- 5648Preclinical efficacy and safety of KIVU-305, a novel CEACAM5-targeting antibody-drug conjugate (ADC) for colorectal cancer (CRC).Ann MacLaren, Natasja N. Viller, Tessie Ng, Liangyi Zhang et al.
- CT156ST316, a first in class β-catenin antagonist, demonstrates safety and efficacy in metastatic colorectal cancer (mCRC)Anthony El-Khoueiry, Susanna V. Ulahannan, Steven Powell, Jason T. Henry et al.
- 1314Circulating tumor DNA (ctDNA) clearance dynamics in microsatellite instability-high metastatic (MSI-H) colorectal cancer (CRC) treated with immune checkpoint inhibitors (ICI).Hannah R. Robinson, Christopher H. Lieu, Vasily N. Aushev, Antony Tin et al.
- LB449Tracing clonal evolution of the human colon from development through aging to understand colorectal cancer initiationJinsil Jeong, Jeong Mo Bae, Seung-Yong Jeong, Ji Won Park et al.
- 1718RT023, a first-in-class CEACAM5/EGFR targeted bispecific antibody drug conjugate (ADC) in colorectal cancer (CRC)Shuting Huang, Lulu Zhou, Jingjing Cao, Lingli Bi et al.
- 3737BXQ-350: A novel biologic that targets dysregulated sphingolipid metabolism and normalizes key anti-tumoral and pro-tumoral sphingolipids in newly diagnosed metastatic colorectal carcinoma patients (mCRC)Gilles H. Tapolsky, TARIQ ARSHAD, Michael Gazda, Jackson Bond et al.
- CT082A phase 1b/2 study of toripalimab and nadunolimab for the treatment of chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC)Jacob Alexander Lowy, Manik Uppal, Matthew D. Park, Kathy H. Wu et al.
- 2569Particle therapy, ATM and PD-1 inhibition for pMMR rectal cancerCameron M. Callaghan
- 293Anti-cancer drug usage analysis among Korean patients with colorectal cancer.Yu Jin Lim, Jeongseon Kim
- 2787Evaluation of imaging-based prognostication (IPRO) using artificial intelligence (AI) in stage IV colorectal cancer (CRC) patients treated with first-line (1L) systemic therapy.Mohammed A. Alvi, Ronald Bridges, Marina Salluzzi, Felipe Soares Torres et al.
- 4708Metabolomics signatures with multidrug-resistant colorectal cancer cellsChristopher Farrell
- LB208
- 3771Monitoring tumor dynamics through circulating cancer stem cells in colorectal cancer patientsMonika Pizon, Dorothea Schott, Ulrich Pachmann, Katharina Pachmann
- 6038Cancer associated fibroblast subtype heterogeneity in colorectal cancer influences primary tumor invasionBethany Haliday, Carly Strelez, Eileen Fung, Shannon M. Mumenthaler
- CT154Clinical activity and safety of novel BRAF inhibitor plixorafenib (FORE8394) in BRAF V600-mutated advanced colorectal cancers (CRC)Rona Yaeger, Sunil Sharma, Aparna Parikh, Stacie Peacock Shepherd et al.
- 7084β-Caryophyllene induces apoptosis and inhibits angiogenesisin colon cancer modelsLoiy Ahmed Hassan, Saad Sabbar, Yasser Tabana
- CT048A first in human, dose escalation (DE) and biomarker cohort expansion (BCE) of IMT-009 (IMT) in advanced cancer and Phase 1b (Ph1b) combination with fruquintinib (F) in microsatellite stable colorectal cancer (MSS CRC)Susanna V. Ulahannan, Melissa Johnson, Jason T. Henry, Shruti Malu et al.
- 4718Redox reprogramming protects colon cancer cells from disulfidptosis under glucose deprivationElimelech Nesher, Subha Ranjan Das, Igor Koman
- 7549Development of personalized medicine strategies for rectal cancerKiki Lianos, Kelly Olsen, Aleksandra Edmundson, Danielle Siganto et al.
- 4351A sex-specific role of CD36 targeting therapy in colorectal cancerHuanyu Wang, Jingying Zhou
- 3624Long-term running and risk of colorectal adenoma and cancerYiwen Zhang, Edward L. Giovannucci
- 3318The regulation of IL-6/gp130 signaling by PTPRF in colon cancerHaley Stanczyk, Carolina Galeano-Naranjo, Tianyan Gao
- 5907Splicing of 3’UTR contributes to colon cancer progressionJiunn Fung Cheong, Xiaonan Fan, Xiao Hong Chew, Yvonne Tay
- 1593Mitochondrial enzyme A promotes macrophage-dependent antitumor responses in colorectal cancerLin Chung, Shi-Chuen Miaw
- 4716Disruption of mitochondrial dynamics alters DNA repair capacity in colon cancerMarion D. Creech, Erin M. Wolf Horrell, Tianyan Gao
- 4126Quantification of step-specific selection reveals ordered acquisition of driver mutations in colon cancerKira A. Glasmacher, Jeffrey Peter Townsend
- 6041Fidaxomicin targets PDGFR+ cancer-associated fibroblast to restrain colorectal cancer progressionHaoxiang Zhang, Xudong Zhu, Chang Li, Yinping Jiang et al.
- CT220A Phase 1b/2a study to evaluate the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma patients (mCRC): Interim efficacy subset analysesDaniel Flora, Ari Baron, Reema Patel, Davendra Sohal et al.
- 991Synergistic effects of antineoplastic drugs and gap junction enhancer in heterogenous colorectal cancerTomas Lugo, Annelise Nguyen
- 847The role of tissue renewal in early-onset colorectal cancer.Bruce M. Boman, Anh Nguyen, Chi Zhang
- 900Risk of second cancer in survivors of early-onset colorectal cancer: racial and ethnic differences in a population-based study.Aniruddha B. Rathod, Caitlin C. Murphy, Sandi L. Pruitt
- 4375Claudin 6 vaccines effectively inhibit tumor growth in a syngeneic mouse colon cancer modelNa Wang, Lam Chow, Melvin Toh, Hong Wang
- 1570Preclinical assessment of EGFR and checkpoint inhibitor combination therapy in spontaneous colon cancer modelBalaji Ramachandran, Satheeshkumar Rajendiran, Girish Joshi, Krishnappa Haladasappa
- 6394Ferroptosis amplified by a tumor-targeted artesunate nano-derivative for effective colon cancer treatment.Jianing Li, Dake Song, Qiutong Guan, Zhenhua Li
- 1800Mitochondrial dysfunction induces asparaginase resistance in R-spondin fusion colorectal cancerSu Hyun Lee, Yun-Cheol Chae, Alejandro Gutierrez
- 4534FGF19/ FGFR4 Axis: A key driver in tumorigenesis and treatment resistance in colorectal cancerAnh Nguyen, Bruce M. Boman
- 6099Identification of key pathways regulating colorectal cancer stemness and metastasis through compound screeningTeruaki Fujishita, Yanqing Niu, Masahiro Aoki
- 3354Chemoradiation treatment increases extracellular vesicle release causing treatment resistance in rectal cancer cell linesVivek Somasundaram, Jeremie M. Lever, Regina Irwin, Teresa C. Beamon et al.
- 6395Enhanced antitumor efficacy of berbamine dihydrochloride nanomedicine via apoptosis induction in colorectal cancer.Chan Zhang, Qiutong Guan, Zhenhua Li
- 3092Epiregulin and amphiregulin as dual targets in colorectal cancerCara Biddle-Guernsey, Joan Jacob, Zhengdong Liang, Kendra S. Carmon
- 4713Targeting glycogen metabolism in cancer-associated fibroblasts alleviates immunosuppression and inhibits colorectal cancer malignancyXudong Zhu, Yuning Zhou, Haoxiang Zhang, Yinping Jiang et al.
- 5768Repurposing veratridine, a previously used antihypertensive supplement, for effective treatment of metastatic colorectal cancerMorgan Eikanger, Khosrow S. Rezvani
- 2367KRAS mutations worsen overall survival (OS) in Black but not White colon cancer patientsSusan Ahmedyar, Minoru Koi, John M. Carethers
- 7374Molecular imaging guided precision radiotherapy and quantitative assessment of metastatic colorectal cancerYunwen Huang, Jiahao Chen, Ning Zhao, Yidong Yang
- 389GSDMB drives cGAS-STING-mediated immune evasion in HER2-amplified colorectal cancer.Junyong Weng, Tianchen Xiong, Xinxiang Li, Ajay Goel
- 3326C-myc driven by differentiation factors in early-onset colorectal cancer (EOCRC)Kazuaki Okamoto, Yalda Naeini, Anton Bilchik, Dave Hoon1.
- 5735Imiquimod targets tankyrase 2 to suppress wnt-active colorectal cancerPhilemon Ubanako, Ramesh Pandian, Adedapo Adeyinka, Bernice Monchusi et al.
- 4707Repurposing statins activates compensatory glutathione metabolism as synergistic vulnerability in colorectal cancerJieqing FENG, Jianming LI, Hong YAN, Zongwei CAI
- 4368Vaccine targeting IGF1R induces neutralizing antibody and robust anti-tumor activity in a syngeneic mouse colon cancer modelKenneth Nansheng Lin, Melvin Toh, HONG WANG
- 2305Contribution of RalA and RalB in colorectal cancer progression and survivalArooj Shafiq, Nazia Jan, Azhar Hussain Rajabali, Kulsoom K. Ghias
- 4847
- 4082The gut microbiota influences chronic sleep deprivation-induced colorectal cancer progression and treatment responseMaria Carolina Hernandez, Ye Yang, Christian Jobin
- 7373An integrated bioinformatic and experimental analysis of radiation-induced epigenetic reorganization in colorectal cancerMegan Tandar, Allison Pittman, Christine E. Eyler
- 4191TP53 dysfunction drives immunometabolic rewiring via mTORC1 activation and autophagy suppression in colorectal cancerEunseuk Lee, Dana Al-Assi, Randy Rueda-Rivera
- 6282Evidence for pathogenicity of inherited biallelic MSH3 variants causing early-onset colorectal cancer.Yuki Aisu, Minoru Koi, John M. Carethers
- 2047Overcoming drug resistance by novel gemcitabine-modified miR-15a in colorectal cancer.Anushka Ojha, Amartya Pal, Max Chao, Ramana Davuluri et al.
- 1877Acquired resistance to Tri-complex inhibitors in colorectal cancer.Sabine Jurado, Simone Lieb, Marco H. Hofmann, Mark Pearson et al.
- 6243Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer.Danny Baxter, Dan Dixon, Andrew Morris, Tongzhang Zheng et al.
- 3421Bioprinted colorectal cancer organoids as a platform for large-scale therapeutic screeningTaehee Kim, Jonathan Levi, Catherine Chen, Lindsay Ng et al.
- 5381Integrated analysis for identification of risk stratification biomarkers for colon cancer.Andrea J. O'Hara, Priya Roy, Dhwani Mulani, Ethan Stancliffe et al.
- 6619Inhibition of PLK4 overcomes radioresistance in locally advanced rectal cancer through genomic instability and apoptotic cell death.Sung Uk Bae, Jeong-Woo Hwang, Hyewon Lee, Hyowon Hong et al.
- 2366HRSNs and CRC screening recommendation in NHISIsaiah Casarez, Humberto Parada, Matthew P. Banegas, Uriel Nataren Geronimo et al.
- 132Improving effector cells for CAR-NK immunotherapy against colorectal cancer.Marco Cortese, Alice D'Andrea, Alfonso Navarro Zapata, Sahar Taebi et al.
- 7002Immune evasive characteristics of the KRAS mutant colorectal cancer tumor microenvironmentElizabeth A. Boeree, Katherine A. Johnson, Cheri A. Pasch, Dustin A. Deming
- 4951
- 2191NQO1 inhibits FBXL14-dependent SNAIL degradation to promote EMT-mediated stemness in colorectal cancer cells.Ha Gyeong Kim, Yunmi Cho, Eun-Taex Oh
- 5900LncRNA UCA1 regulates LDHA expression to drive Warburg metabolism and colorectal cancer progressionSalique H. Shaham, Ricardo Pequeno Bracho, Kaylee Renteria, Manish Tripathi
- 6122Organ-specific immune and metabolic programs shape spatial microenvironments in MSS colorectal cancer metastasesJian Ye, Colt A. Egelston, Chongkai Wang, Marwan Fakih
- CT170Neoadjuvant pembrolizumab stratified by tumor mutation burden in high-risk stage II-III dMMR/MSI colorectal cancer (NEOPRISM-CRC): Perioperative ultrasensitive ctDNA monitoring and tumor-infiltrating TCR repertoire for treatment response predictionYanrong Jiang, Anna-Maria Militello, Charles Abbott, Bailiang Li et al.
- CT184Preliminary results of first-line botensilimab (BOT) and balstilimab (BAL) optimization in microsatellite stable colorectal cancer (MSS CRC) without liver, bone, or brain metastasis (BBOpCo)Nicholas C. Devito, Emily Bolch, Aman Opneja, Hope Uronis et al.
- 6049Cartilage oligomeric matrix protein, cancer-associated fibroblast phenotypes, and versican proteolysis modulate CD8+ T cell infiltration in colorectal cancerCadence E. Brown, Ruchi Shah, Cindy Wuerz, Isoline M. Donohue et al.
- 3946Association between MLK4 expression and colon cancer patient survival.Nathan Kumar, Hitesh Kapoor, Piush Srivastava, Deepti Srivastava et al.
- 3402THSD7B loss is associated with oxaliplatin resistance in colorectal cancer patient-derived tumor organoidsGraziana Spoto, Luca Falzone, Marco Fichera, Massimo Libra
- 7046BRAF/EGFR inhibition induces ERBB2 as a targetable tolerance mechanism in BRAF -mutant colorectal cancer.Sara Peltola, Kari J. Kurppa, Klaus Elenius
- 5072Discriminatory capacity of allostatic load score in colorectal cancer: A pilot case-control studyHilmaris Centeno-Girona, Maria Gonzalez-Pons, Elba V. Caraballo-Rivera
- 4671Autophagy alterations in KRAS-mutant colorectal cancer following PRMT5 inhibitionKomalpreet Kaur, Danbee Chae, Daniel Aguaiza, Netanel Louloueian et al.
- 1330Targeting Aurora kinase A for potentiating colorectal cancer to KRAS targeted therapy.Zhaojin Liu, Ning Wei, Suisui Hao, Xinyan Lu et al.
- 2267Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer.Haylee Duval, Barbara Toomey, Michelle Karam, Brian Nestor et al.
- 7379FDXR expression is a rectal cancer biomarker of radiation resistance and confers resistance through ferroptosisSara Soltani Tehrani, May Zin Hlaing, Joseph Fedro, Rami-James Aoun et al.
- LB239Spatial programs of cancer-associated and normal fibroblasts diverges with mismatch repair status in colorectal cancerDebanjan Barua, Tze Guan Tan, Shu Wen Samantha Ho, Michael T. Wong et al.
- 1744CRISPR screening identifies SMARCAL1 and MRN as modulators of WRN dependency in MSI-H colorectal cancerTiantian Ma, Jibo Wu, Siting Li, Junjie Chen
- 4685Intestinal inflammation triggers POLE P286 R-driven ultramutated colorectal cancerMd Kawsar Mustofa, He Zhang, Diego H. Castrillon, Hasan Zaki
- 5904Long noncoding RNA, RAMS11, promotes DNA damage response in colorectal cancerYesol Kim, Shilpa Hebbar, Nicole White, Amy Ly et al.
- 88Multiscale characterization of early morphologic radiation response in rectal cancer via digital pathology.Sriya Veerapaneni, Paul Acosta, Bassel Dawod, Sebastian Diegeler et al.
- 5441Structural and kinetic effects of R361H SMAD4 mutation on TGF-ß signaling in colorectal cancer.Evan Boczko, Isaac Silverman, Yisrael Wiener, Sanjay Goel et al.
- 5961The roles of METTL3 in colorectal cancerHung Mai, Sidi Zhao, DEBANJAN SAHA, Jace Webster et al.
- 3107CWH43 emerges as a novel therapeutic target linked to chemoresistance in colorectal cancerYu-Jia Chang, Chien-Yu Huang, Po-Li Wei, Cheng-Chin Lee
- 7297HIF-1α pathway is a therapeutic vulnerability in mucinous colorectal cancerYoojeong Seo, Jinho Jang, Kyung-Pil Ko, Jie Zhang et al.
- 7277
- CT084A Phase 1b/2a study to evaluate the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma patients (mCRC): Evidence of lower incidence and severity of CIPN eventsReema Patel, Daniel Flora, Ari Baron, Davendra Sohal et al.
- 5052A network approach using Gaussian graphical models to evaluate dietary patterns and colorectal cancer risk in the UK BiobankJiyoung Hwang, Sooyoung Cho, Aesun Shin
- 4945Distinct colorectal cancer tumor cell subtypes revealed by single-cell and spatial transcriptomicsJi Hye Choi, Yeong Hak Bang, Kyung Yeon Han, Woong-Yang Park
- 4672Neuropeptide Y Y1 receptor inhibition induces autophagy to limit colorectal cancer progressionSooraj Kakkat, Prabhat Suman, Aris Richter, Steven B McClellan et al.
- 1853NAT10-mediated ac4C RNA modification promotes colorectal cancer stemness and 5-FU resistance via ATG5-dependent autophagy.Xin Kong, Junyong Weng, Zhe Wang, Ajay Goel
- 6043Deactivating liver metastatic colorectal cancer-associated fibroblasts with all-trans retinoic acidBrandon Choi, Ken Huang, Yuyuan Zhou, Seungil Kim et al.
- 7324HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancerMoeez Ghani Rathore, Chao Wei, Kimberly Curry, Mehrdad Zarei et al.
- 3411Mechanochemical effects of growth factor gradients in colorectal cancer organoidsGabriel L. Declercq, Alex Borowiec, Alejandro Moncada, Alia Starman et al.
- 5116Assessing blood- and stool-based tests for colorectal cancer detectionJames M. Cameron, Holly Butler, David Palmer, Rose McHardy et al.
- 3836IGF system genes as colorectal cancer biomarkers in Puerto RicoHilmaris Centeno-Girona, Camille Zenon-Melendez, Sheila Natalie Lopez Acevedo, Ingrid Montes-Rodriguez et al.
- 2750Rapid curation of colon cancer cohorts using on-site peta-scale language model for MSI classification from pathology reports.Joshua Jay Levy, Nathalie Nguyen, Minh-Khang Le, Keluo Yao et al.
- 500Co-occurrence of gene fusions and microsatellite instability (MSI) defines a clinically distinct subtype of colorectal cancer.Scott Kulm, Sebastià Franch-Expósito, Paul Fields, Catherine Igartua
- 879Utilization of pelvic floor therapy after a colorectal cancer diagnosis in a universal-access health system.Kimberly R. Robins, Yvonne Eaglehouse, Craig D. Shriver, Kangmin Zhu
- 306Integrative computational and functional genomic approach reveals UBE2Z-UBR2-Ecadherinaxis as a beta-catenin-specific vulnerability in colorectal cancer.Chunhua Wan, Hugh Gao, Claire Sun, Ron Firestein
- 5707Mechanism of action of GEM144, a POLA1-HDAC11 dual inhibitor, in colorectal cancer modelsRana Abdel-Samad, Avery Lazaro, Maura Mack, Berthe Hayar et al.
- 7285Gene expression-based subtypes associated with prognosis in Colombian colorectal cancerWendy Johana Montero Ovalle, Diego Felipe Ballen-Lozano, Liliana López-Kleine, Silvia Juliana Serrano-Gomez
- 4704Disruption in cholesterol homeostasis by free fatty acid promote colon cancer by modulating CCL20Janani Muralidharan, Ankit Bhatt, Jaliya M. Mims, Gene Hughes et al.
- 4137The acidic tumor microenvironment facilitates colorectal cancer liver metastasis through LPL lactylation-mediated reprogramming of macrophage cholesterol metabolismYifan Zheng, Zhengyu Wei, Zhengran Zhou, Peishan Hu
- 6157Single-cell characterization of tumor niches driving liver metastasis in colorectal cancerJinho Jang, Yoojeong Seo, Kyung Pil Ko, Jie Zhang et al.
- 6244Agricultural glyphosate use and early-onset colorectal cancer mortality in the United States.Jiayu Lin, Malia Cortez, Caroline Nondin, Seigi Karasaki et al.
- 4144Immunotherapy response predictors in colorectal cancer: A multi-omics approachJoaquin Pedro Merlo, Marco Adrian Scheidegger, Ada G. Blidner, Alejandro Cagnoni et al.
- 5297Distinct genomic and pathway-level alterations in early-onset colorectal cancer: A large-scale Korean cohort analysisAh Reum Lim, Boyeon Kim, Minsoo Kim, Soohyeon Lee
- 6419Automated culture and AI-enabled image analysis of compound responses in patient-derived colorectal cancer organoidsOksana Sirenko, Prathyushakrishna Macha, Zhisong Tong, Nikki Carter et al.
- 2083Spatial profiling reveals distinct immune microenvironments in early vs late onset colorectal cancer.Niti Jani, Michael Martinez, Christopher Flynn, Hatano Yuichiro et al.
- 7571Health literacy and colorectal cancer: A targeted review of screening, outcomes, and challenges in vulnerable populations.Nijole P. Tjader, Brigette Waldrup, Hyoshin Kim, Enrique I. Velazquez Villarreal
- 581FUT8-mediated fucosylation promotes colorectal cancer growth and metastatic potential via tumor-fibroblast interactions.Zimo Huang, Sree K. Kondapuram, Xiang Y. Zheng, Praveen Agrawal et al.
- 3799HER3 inhibition sensitizes metastatic colorectal and pancreatic cancer to immunotherapyChao Wei, Moeez Ghani Rathore, Elizabeth Bryson, Kimberly Curry et al.
- 4711Investigating synergistic impact of diet-induced hyperinsulinemia and mutant Kras on colorectal cancer metastasisAnindita Mahanty, Cara Wallingford, Alexa Magstadt, Revan Hammontree et al.
- 3430NR4A3 functions as an immuno-metabolic checkpoint in tumor-associated macrophages to mediate radiotherapy sensitivity in rectal cancerXiaowan Guo, Gan Tao, Xiuli Guo, Kehua Hu et al.
- 5115A multi-omic liquid biopsy for the earlier detection of colorectal cancerJames M. Cameron, Holly J. Butler, David S. Palmer, Rose G. McHardy et al.
- 2383The stress survival gene CCNB1 drives colorectal cancer progression and represents a novel target to address ethnic disparitiesMd Zahirul Islam Khan, Urbashi Basnet, Soumya Nair, Sourav Roy
- LB204Prevalence and predictors of colon cancer screening among an Afro-Caribbean cohort: Insights from the Living in Full Health projectYvonne Dawkins, Natalie Guthrie-Dixon, Kimlin Tam Ashing, Camille Ragin et al.
- LB164Mutational signatures associated with Western dietary patterns in colorectal cancerMariya Kazachkova, Thomas Cattiaux, Ammal Abbasi, Mathilde Meyenberg et al.
- 3116CDK4/6 inhibition overcomes 5-FU resistance by suppressing TYMS-driven R-loop-associated DNA damage in colorectal cancerLingling Xu, Jiabei Zhu, Jinghua Sun, Man Li et al.
- 4948Spatial architectures of colorectal cancer microenvironment underlying immune checkpoint inhibitor responseChuyan Liu, Hang Yin, Joon Sang Lee, Julien Tessier et al.
- 1961DNA methylation signatures associated with tumor location in early-onset colorectal cancer identified across two independent cohorts.Aniruddha B. Rathod, Sandi L. Pruitt, Amit G. Singal, Caitlin C. Murphy
- 2463Microbiota-dependent complex dietary polysaccharide degradation suppresses inflammaging and colorectal cancer susceptibilityRekha Jalandra, Mousumi Bhattacharjee, Ruchika Maurya, Radhika R. Gudi et al.
- 318The combination of STX-478 and lorlatinib for the treatment of PIK3CA mutant colorectal cancer.Addison T. Zick, Alexa E. Schmitz, Cheri A. Pasch, Dustin A. Deming
- 4257F5446 epigenetically reprograms T cells to boost CEA CAR T cell immunotherapy efficacy in human colorectal cancer metastasisKendra Fick, Patrick Czabala, Zainab Tiamiyu, Dafeng Yang et al.
- 7088NAD(P)H: Quinone oxidoreductase 1 (NQO1): Is it a potential molecular target in colorectal cancerChaithanya Ganji, Raasil R. Basha, Karthikeya Ganji, Mehmet Akce et al.
- 3119Modeling chemotherapy persistence in colorectal cancer using patient-derived organoidsYasmine Abouleila, Timo Voskuilen, Mayke Doorn, Roel Verkerk et al.
- 4712Targeting NRF2-regulated polyamine and glutathione metabolism enhances chemotherapy efficacy in colorectal cancer based on KRAS statusJiamin Li, Jieqing Feng, Fuyue Wang, Yingjie Zhang et al.
- 2873Neurotensin suppresses anti-tumor immunity and is associated with poor prognosis in colorectal cancerHaoming Wu, Yang Wang, Dana Napier, Hong Jiang et al.
- LB172RNA-seq-based molecular and microenvironmental stratification of colorectal cancer in a Korean real-world cohortJinseon Yoo, Kyu Jin Song, Jimin Kim, Keeok Haam et al.
- 4903Explore the effects of Fusobacterium nucleatum on chemotherapy response in colorectal cancer at spatial and single-cell resolutionYuting Shan, Lilin Wang, Matthew Jeon, R. Stephanie Huang
- 4913Single-cell intercellular CRISPR screen reveals stromal regulators of colorectal cancer plasticityCorinne Molyneux, Rhianna O'Sullivan, Alistair Wilkinson, Nick Li et al.
- 5452Deep learning enables matched-normal free estimation of tumor mutational burden from whole exome reads in colorectal cancer.Amrita Chattopadhyay, Liang-Yu Lin, Ching-Tai Chen, Eric Y. Chuang
- 7698Advancing plasma proteomics: A next-generation nanoparticle enrichment workflow for deep and quantitative biomarker discovery in colorectal cancerCameron Ellis, Katharina Limm, Sandra Schär, Roland Bruderer et al.
- 7715Elevated baseline DKK1 plasma is a biomarker for sirexatamab treated colorectal cancer patientsZongzhong Tong, Scott Patton, Patty Ormonde-Hanson, Calvin Jia et al.
- 3938Scalable AI-driven tumor-stroma ratio quantification for prognostic stratification in stage II-III colorectal cancer.Wei Kit Tan, Marcia Zhang, Juha P. Väyrynen, Shuji Ogino et al.
- 4886Integrative analysis reveals bacterial load as a determinant of molecular and immune phenotypes in colorectal cancerSubha Singh, Travis D. Kerr, Melissa Lumish, Ying Ni et al.
- 4866Interactions between colorectal cancer cells and cancer-associated fibroblasts across desmoplastic reaction subtypesWataru Kosaka, Keigo Murakami, Yota Akamori, Hideaki Karasawa et al.
- 822Netrin-1/UNC5B-TFF3 axis modulates cancer stem cells self-renewal and chemoresistance in metastatic colorectal cancer.Morgan Brisset, Kristina Radkova, Andrea Paradisi, Lea Stephan et al.
- 1504Fusobacterium-driven epithelial-stromal remodeling in CRCSabin Park, Taeyul Kim, Kyung-A Kim, Minsun Jung et al.
- 3622Precision therapy against CRC associated Fusobacterium nucleatum using bioengineered probiotics expressing guided antimicrobial peptides (gAMPs)Ankan Choudhury, Colin Scano, Allison Barton, Leigh Greathouse
- LB367Novel non saccharide glycosaminoglycan mimetic inhibit colorectal cancer stem cells by selectively targeting key tyrosine kinase receptorsShoja M. Haneefa, Bharath Villuri, Rio Boothello, Priyanka Mishra et al.
- 4197Multiomic dissection of KRAS signaling reveals targetable metabolic and DNA repair vulnerabilities in colorectal cancerTom Cohen, Ashima Mehta, Adam Richardson, Monil Gandhi et al.
- 7621Early-onset colorectal cancer detection through a non-invasive label-free electrochemical immunosensor probeRuma Paul, Md Zahirul Islam Khan, Soumya Nair, Alicia I Loya et al.
- 5037Liquid and solid fructose intake and colorectal cancer mortality by physical activity in U.S. prospective cohortsHanseul Kim, Jihye Yun, Carrie R. Daniel-MacDougall, Long H. Nguyen et al.
- 702Harnessing clonal dynamics to overcome resistance: An adaptive therapy framework in colorectal cancer.Harley I. Richker, Bailey Sierra Kane, Gissel Marquez Alcaraz, Ellie Pahl et al.
- 7371High-definition spatial and single-cell multiomics reveal immunological remodeling and radiation resistance mechanisms in colorectal cancerJunbum Kim, Olivier Elemento, Christina Montagna, Nir Ben Chetrit et al.
- 1943Epigenomic evolution during tumorigenesis in colorectal cancer.Chang Hyun Nam, Yunah Lee, Yeonjin Kim, Hyein Won et al.
- 5457From tumor to model: Transcriptomic and therapeutic insights from patient-derived colorectal cancer organoids.Matthew Graziano, Ajeet Singh, Stephen Friend, Ruby E. Thamert et al.
- 4
- 7909Exploring a LINC00092-associated multiomics signature as a clinically tractable biomarker in colorectal cancerPankaj Kumar Ahluwalia, Alicia Walker, Sade Logan, Denton Lord et al.
- 7604Disaggregating Latino nativity using machine learning on electronic health records: Insights for colorectal cancer screening disparities.Miguel Marino, Jun Hwang, Jennifer A. Lucas, Wyatt Bensken et al.
- 5077Investigating IL-6-driven inflammation and gene-environment interactions in colorectal cancer disparities among Puerto Rican HispanicsLuis Daniel Borrero-Garcia, Melissa Chavez, Olga Díaz-Miranda, Leslie Casiano et al.
- 387Precision combination therapy opportunities in colorectal cancer revealed by PDX drug screening.Alexey Sorokin, Preeti Kanikarla Marie, Jay Saynonh, Christian Beke Onana et al.
- 3575Early-onset colorectal and pancreatic cancer in the United States: Incidence and mortality projections through 2040Woo Joo Lee, Sumbal Aziz, Seon Hye Won, Muhammad Sohaib Asghar et al.
- 6259Circadian disruption from time zone position and risk of colorectal cancer precursors in women.Bethsaida Cardona, Trang VoPham, Kyriaki Papantoniou, Eva Schernhammer et al.
- 4380IRZ-01: A self-adjuvanted outer membrane vesicle vaccine targeting CEA and MUC1 for colorectal cancer immunotherapyKevin Chen, Caleigh Fletcher, John Cowger, James E. Galen et al.
- 6208Subcellular imaging of murine models of metastatic colorectal cancer using a whole transcriptome spatial molecular imaging panelLiang Zhang, Isabel Lee, Shanshan He, Martin Shelton et al.
- 5010
- 5455RNA-seq profiling identifies FOX genes as potential CRC biomarkers.Yakshi Nicole Ortiz-Maldonado, Hilmaris Centeno-Girona, Camille Zenon-Melendez, Sheila Natalie Lopez-Acevedo et al.
- 3523Immunological roles of antigen-presenting cancer-associated fibroblasts and mesothelial cells in colorectal cancerYasuhiro Fukui, Hiroaki Kasashima, Yukina Kusunoki, Nobuhiro Naito et al.
- 3654Plant-derived exosomes from black soybeans for combatting pancreatic and colon cancer cellsZhangzhu Ruixian, Makiko Nakahana, Yasuyuki Shimizu, Mohammed Salah et al.
- 7439SPP1 positive macrophage spatial feature correlation to stage III-IV colon cancer multiple pathology parametersShaojun Xu, Hongzhe Sun, Shuo Han, Lin Zhu et al.
- 4710Comprehensive metabolomic profiling of FFPE human tissues reveals key metabolic reprogramming in colorectal cancer and associated pathwaysTom Cohen, Ashima Mehta, Adam Richardson, Monil Gandhi et al.